Answers are grounded in this paper and cite their sources.
Observational analysis reveals CXCR-4 PET/CT effectiveness in MALT lymphoma, suggesting potential for better diagnosis and treatment.
Mucosa-associated lymphoid tissue lymphoma (MALT lymphoma) is an indolent B-cell non-Hodgkin lymphoma originating from post-germinal center marginal zone B cells. It typically arises in mucosal sites due to chronic antigenic stimulation from autoimmune disorders or persistent infections (e.g., Helicobacter pylori in gastric MALT lymphoma) [1]. It accounts for 5–8% of all B-cell lymphomas, and is the most common extra-nodal marginal zone lymphoma, with an annual incidence of 1–2 cases per 100000 [2]. Common sites include the stomach, salivary glands, ocular adnexa, lung (where it is known as bronchus-associated lymphoid tissue lymphoma), thyroid, and, less frequently, the skin or intestine. Approximately 35–50% of cases occur in the stomach.
No takes yet. Share an insight, caveat, or question.
LIN et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: